Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease

Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease

Abstract Introduction Pneumococcal disease, which presents a substantial health and economic burden, is prevented through pneumococcal vaccination programs. We assessed the impact of switching from a 13-valent-based (PCV13) to lower 10-valent-based (PCV10-GlaxoSmithKline [GSK] or PCV10-Serum Institu...

Full description

Bibliographic Details
Main Authors: Liping Huang, Cheryl L. McDade, Johnna E. Perdrizet, Michele R. Wilson, Sophie A. Warren, Susan Nzenze, Renilla Sewdas
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-02-01
Series:Infectious Diseases and Therapy
Subjects:
PCV
PCV13
PCV20
Pneumococcal disease
Vaccine
Online Access:https://doi.org/10.1007/s40121-023-00767-4

Internet

https://doi.org/10.1007/s40121-023-00767-4

Similar Items